“In my role at Covance I had the opportunity to interface with Andy in capital investment discussions and scientific updates around his areas of responsibility. Andy has a strong balance between scientific and client and business. Honestly, this is not extremely common in my experience. Andy was successful in navigating significant investment for technology that delivered value for our clients and our business. Andy has a great appetite for growth and development and seems to have infinite capacity. I believe Andy’s capabilities are unique in our industry and I would highly recommend Andy as a leader among leaders to drive positive changes and success.”
– Michael J. Lehmann, President Global Pharmaceutical Development Services and Interim EVP of Global Sales and Marketing at Patheon Inc.
“Andy is a dedicated scientist focused on client driven innovation. He developed a global program for continuous infusion route of administration by using commercial insight to listen closely to clients needs. Co-operating closely with global colleagues Andy launched an innovative new service for global clients. As a commercially aware scientist Andy has multiple skills sets and would be a valuable asset to a progressive scientific organisation.”
– Alan Findlater, Chief Commercial Officer at WIL Research